Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EXU | Bankers/Brokers or RMS | 01/08/19 | 108 | 31K | |||
|
|||||||
EXU | Compulsory Acquisition - RMS Shares | 04/04/19 | 0 | 1.1K | |||
|
|||||||
EXU | Ann: Removal from Official List | 08/03/19 | 0 | 1.3K | |||
|
|||||||
EXU | Ann: Change of Director's Interest Notice | 06/03/19 | 0 | 1.5K | |||
|
|||||||
EXU | Ann: Final Director's Interest Notice | 06/03/19 | 0 | 768 | |||
|
|||||||
EXU | Ann: Final Director's Interest Notice | 06/03/19 | 0 | 743 | |||
|
|||||||
EXU | Ann: Director Resignations | 06/03/19 | 0 | 1.1K | |||
|
|||||||
EXU | Ann: Details of Company Address | 06/03/19 | 0 | 756 | |||
|
See All Discussions